Cargando…
Current Status and Perspective of Immunotherapy in Gastrointestinal Cancers
Cancer immunotherapy is at dawn of the Renaissance after the Medieval Dark Ages. Recent advances of understanding tumor immunology and molecular drug development are leading us to the epoch of cancer immunotherapy. Some types of immunotherapy have shown to provide survival benefit for patients with...
Autores principales: | Kim, Jung Hoon, Kim, Bum Jun, Kim, Hyeong Su, Kim, Jung Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039380/ https://www.ncbi.nlm.nih.gov/pubmed/27698896 http://dx.doi.org/10.7150/jca.16208 |
Ejemplares similares
-
Current Status of Immune Checkpoint Inhibitors in Gastrointestinal Cancers
por: Kim, Bum Jun, et al.
Publicado: (2017) -
Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
por: Lu, Zhihao, et al.
Publicado: (2020) -
Current Status of Immunotherapy for Lung Cancer and Future Perspectives
por: Kim, Ho Cheol, et al.
Publicado: (2020) -
Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy
por: Hazama, Shoichi, et al.
Publicado: (2018) -
Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017)